Sandy Cove Advisors’s Organon & Co OGN Stock Holding History

Sandy Cove Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-246	Closed	-$9K	–	289
2022 Q1	$9K	Hold	246	–	–	0.01%	328
2021 Q4	$7K	Buy	+246	New	+$8.01K	0.01%	312

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sandy Cove Advisors's OGN Position: Q2 2022 in Review

Sandy Cove Advisors sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 246 shares — an estimated $9K sold.

Sandy Cove Advisors first reported a position in OGN in Q4 2021 and held it in 2 quarters. The position peaked at $9K in Q1 2022. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

Sandy Cove Advisors reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
Sandy Cove Advisors sold 246 Organon & Co shares in Q2 2022, an estimated $9K.
Sandy Cove Advisors first reported a position in Organon & Co in Q4 2021 and held it in 2 quarters.
Sandy Cove Advisors's Organon & Co position peaked at $9K in Q1 2022.
853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Sandy Cove Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.